Olson Eric R
- SEC CIK
- 0001678149
No open-market purchases or sales filed in the past year.
Current role at each company
- SYRS Syros Pharmaceuticals, Inc.Chief Scientific Officeras of Jul 18, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Olson Eric R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 (view filing) | Jul 1 | Same day | Olson Eric RChief Scientific Officer | SSale | −1.16K | $5.55 | −$6.46K | −100.0%0 after | |
| Jan 6, 2022 (view filing) | Jan 5 | 1 day | Olson Eric RChief Scientific Officer | SSale | −2.21K | $3.47 | −$7.66K | −100.0%0 after | |
| Jul 18, 2023 (view filing) | Jul 17 | 1 day | Olson Eric RChief Scientific Officer | SSale | −689 | $3.50 | −$2.41K | −9.4%6.66K after | 10b5-1 |